Josephine "Josie" Martin is Executive Vice President of Public Affairs for the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical research companies. She leads PhRMA’s communications and alliance development functions and serves as a key advisor to PhRMA’s president, management and Board of Directors.
Working at the intersection of public policy, health and business, Ms. Martin oversees PhRMA’s public affairs efforts to support an environment that fosters medical innovation, new drug discovery and access to life-saving medicines.
In a career spanning more than 20 years, Ms. Martin has established herself as a leading healthcare communications and public affairs expert. Prior to joining PhRMA, she served as Senior Vice President at Ketchum, where she built a widely respected public affairs health care practice and provided counsel to a wide range of blue chip corporate clients and several leading non-profit organizations. Ms. Martin was also Senior Vice President of Public Affairs at GolinHarris, where she oversaw advocacy efforts for a wide array of healthcare clients, including America on the Move, Olympus, Dow Chemical Company, Kaiser Permanente, Boehringer Ingelheim, Robert Wood Johnson Foundation, and drugstore.com, among others. Under her leadership, the American Legacy Foundation launched the largest public health cessation program in 40 years. She also developed the advocacy strategies for Olympus in Washington, D.C., with a focus on colorectal cancer awareness, medical device regulation, and business opportunities within the 2009 stimulus program.
Ms. Martin has also held leadership positions with the Federation of American Hospitals (FAH), the Health Insurance Association of America (HIAA), and the American Red Cross. In addition, she served as Communications Director to the Senate Finance Committee and Press Secretary to Senator John Chafee (R-RI).